🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 2 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/08/2002 20,70 21,48 20,46 21,24 +2,61% 4,93% 9.233
21/08/2002 21,30 21,30 19,80 20,70 -1,99% 7,04% 23.433
20/08/2002 20,94 21,42 20,46 21,12 +4,45% 4,58% 13.267
19/08/2002 20,70 20,70 19,80 20,22 -0,59% 4,35% 30.017
16/08/2002 20,40 21,30 20,22 20,34 -2,31% 5,29% 27.233
15/08/2002 20,40 21,36 19,74 20,82 +0,29% 7,94% 24.583
14/08/2002 20,64 20,94 19,50 20,76 -1,14% 6,98% 38.733
13/08/2002 21,12 21,12 19,80 21,00 -1,13% 6,25% 27.467
12/08/2002 21,48 21,60 21,06 21,24 +0,85% 2,51% 4.650
09/08/2002 20,28 21,30 18,00 21,06 +3,85% 16,27% 25.483
08/08/2002 19,50 20,28 18,78 20,28 +2,42% 7,69% 17.250
07/08/2002 19,50 19,98 18,96 19,80 +1,54% 5,23% 8.783
06/08/2002 18,60 19,80 18,00 19,50 +3,50% 9,68% 10.750
05/08/2002 18,60 18,90 18,12 18,84 -2,48% 4,19% 7.417
02/08/2002 21,96 21,96 18,90 19,32 -9,30% 13,93% 16.567
01/08/2002 22,80 23,04 21,30 21,30 -4,05% 7,63% 6.550
31/07/2002 22,44 23,04 21,78 22,20 -1,07% 5,61% 11.800
30/07/2002 22,92 22,92 21,60 22,44 +1,08% 5,76% 13.567
29/07/2002 23,82 23,94 22,20 22,20 -3,90% 7,30% 21.417
26/07/2002 22,50 23,94 22,20 23,10 +2,12% 7,73% 39.317
25/07/2002 19,14 22,74 18,96 22,62 +18,55% 19,75% 59.967
24/07/2002 18,18 19,20 17,76 19,08 +2,58% 7,92% 9.550
23/07/2002 18,24 18,60 17,76 18,60 +0,65% 4,61% 19.067
22/07/2002 18,90 18,90 18,06 18,48 -3,14% 4,44% 14.950
19/07/2002 19,02 19,44 17,82 19,08 +0,00% 8,52% 67.250
18/07/2002 18,00 19,14 17,52 19,08 +6,00% 9,00% 10.783
17/07/2002 16,50 18,30 16,50 18,00 +10,70% 10,91% 47.000
16/07/2002 16,50 17,88 15,00 16,26 -9,06% 17,45% 18.800
15/07/2002 17,70 17,94 15,00 17,88 +5,67% 16,61% 34.867
12/07/2002 17,76 18,12 16,80 16,92 -4,41% 7,43% 25.150